IVD Technology
September 1998
Selected Contents
COVER STORY:
Coagulation testing, Part 2: The quest to optimize near-patient analyzers
by David G. M. Carville and Kirk E. Guyer
Near-patient coagulation testing offers substantial benefits for both patients and the institutions that care for them. The features of today's analyzers make them portable, easy to use, and capable of performing a number of different tests at the patient's bedside.
DNA-chip technologies
Part 1: Research fundamentals and industry catalysts
by Cliff Henke
In this first installment of a special three-part series,
IVD Technology looks at the basic elements of DNA-chip technologies and the forces that are advancing research
in the field.
The role of membranes in molecular diagnostics
by Jason M. Alter
With the rise of molecular diagnostics, researchers are exploring new applications for membranesfamiliar materials with a proven track record.
Commentary: Medicare's negotiated rule making
by Ted Mannen
A committee of 16 organizations is negotiating the future of reimbursement for clinical laboratory testing. Now is the time for manufacturers to make their needs known.
Regulations and Standards: FDA makes a better rule for IHCs
by Jeffrey N. Gibbs
Industry had a lot to say about FDA's 1996 proposed rule on immunohistochemicals. To judge from the final rule, the agency was listening.
Editor's Page
IVD Technology News
Safer foods through IVD testing
New heart disease marker on the way?
Visible Genetics gets virtual DNA sequencer patent
More changes and challenges for Oncor
1998
July/August | May/June | March/April | January/February
1997
November/December |
September | July/August | May/June
March/April |
January/February



